References
- Akaike H. 1974. A new look at the statistical model identification. Automatic Control, IEEE Transact 19:716–723.
- Bond GL, Hirshfield KM, Kirchhoff T, Alexe G, Bond EE, Robins H, Bartel F, Taubert H, Wuerl P, Hait W, Toppmeyer D, Offit K, Levine AJ. 2006. MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res 66:5104–5110.
- Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ. 2004. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119: 591–602.
- Budworth H, Snijders AM, Marchetti F, Mannion B, Bhatnagar S, Kwoh E, Tan Y, Wang SX, Blakely WF, Coleman M, Peterson L, Wyrobek AJ. 2012. DNA repair and cell cycle biomarkers of radiation exposure and inflammation stress in human blood. PloS one 7:e48619.
- Chiba M, Miura T, Kasai K, Monzen S, Kashiwakura I, Yasue H, Nakamura T. 2012. Identification of up-regulated and down- regulated cis-natural antisense transcripts in the human B lymphoblastic cell line IM-9 after X-ray irradiation. Mol Med Rep 5:1151–1157.
- Ellis NA, Huo D, Yildiz O, Worrillow LJ, Banerjee M, Le Beau MM, Larson RA, Allan JM, Onel K. 2008. MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood 112:741–749.
- Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K. 2004. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 64:8891–8900.
- Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B. 2002. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 109:1625–1633.
- Hartford CM, Dolan ME. 2007. Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity. Pharmacogenomics 8:1159–1168.
- Jin L, Ai X, Liu L, Wang Z, Cheng Y, Qiao Z. 2006. Testosterone induces apoptosis via Fas/FasL-dependent pathway in bone marrow-derived macrophages. Methods Find Exp Clin Pharmacol 28:283–293.
- Lacher DA, Barletta J, Hughes JP. 2012. Biological variation of hematology tests based on the 1999–2002 National Health and Nutrition Examination Survey. Natl Health Stat Report 1–10.
- Morkuniene R, Arandarcikaite O, Borutaite V. 2006. Estradiol prevents release of cytochrome c from mitochondria and inhibits ischemia-induced apoptosis in perfused heart. Exp Gerontol 41:704–708.
- Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, Zhu M, Wu TY, Jenkins GD, Batzler A, Wang L. 2010. Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res 20:1482–1492.
- Shukla SJ, Dolan ME. 2005. Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies. Pharmacogenomics 6: 303–310.
- Tollerud DJ, Clark JW, Brown LM, Neuland CY, Pankiw-Trost LK, Blattner WA, Hoover RN. 1989. The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers. J Clin Immunol 9:214–222.
- Utsuyama M, Hirokawa K, Kurashima C, Fukayama M, Inamatsu T, Suzuki K, Hashimoto W, Sato K. 1992. Differential age-change in the numbers of CD4 + CD45RA+ and CD4 + CD29+ T cell subsets in human peripheral blood. Mech Ageing Dev 63:57–68.
- Vasconsuelo A, Pronsato L, Ronda AC, Boland R, Milanesi L. 2011. Role of 17beta-estradiol and testosterone in apoptosis. Steroids 76:1223–1231.
- Veldwijk MR, Trah J, Wang M, Maier P, Fruehauf S, Zeller WJ, Herskind C, Wenz F. 2011. Overexpression of manganese superoxide dismutase does not increase clonogenic cell survival despite effect on apoptosis in irradiated lymphoblastoid cells. Radiat Res 176:725–731.
- Wilcoxon F. 1946. Individual comparisons of grouped data by ranking methods. J Econ Entomol 39:269.
- Williams D. 2008. Radiation carcinogenesis: Lessons from Chernobyl. Oncogene 27(Suppl. 2):S9–18.